P Mickey Williams

28PUBLICATIONS
201CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 11, 2026
ERK1/2 Inhibitor Ulixertinib in Pan-cancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L.

|Aug 07, 2026
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay.

|Jan 20, 2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Niamh Coleman, Zihan Wei, A John Iafrate

|Jun 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K.

Carolyn K McCourt, Zihan Wei, Kevin Kalinsky

|Jun 04, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial.

Linda K Zane, Laura M Yee, Ting-Chia Chang

|May 19, 2025
Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131).

Mohamed A Gouda, Filip Janku, Ying Yuan

Pageof 5

Frequent Collaborators

22 joint publications

David R Patton

20 joint publications

Keith T Flaherty

19 joint publications

James V Tricoli

19 joint publications

Stanley R Hamilton